Condition: Colon Cancer · Rectal Cancer · Colon Neoplasm · Sponsor: Freenome Holdings Inc.
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Central Alabama Research | Birmingham, Alabama, United States | — |
| Alabama Oncology | Birmingham, Alabama, United States | — |
| Clinical Research Associates | Huntsville, Alabama, United States | — |
| Del Sol Research Management | Chandler, Arizona, United States | — |
| Honor Health | Scottsdale, Arizona, United States | — |
| Del Sol Research Management, | Tucson, Arizona, United States | — |
| Preferred Research Partners | Little Rock, Arkansas, United States | — |
| Highlands Oncology Group | Springdale, Arkansas, United States | — |
| Precision Research Institute | Chula Vista, California, United States | — |
| John Muir Health | Concord, California, United States | — |
| Carbon Health | Corona, California, United States | — |
| Miller Bioconnect | El Cajon, California, United States | — |
+ 136 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.